F573 for Injection

· Beijing Continent Pharmaceutical Co, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for F573 for Injection, covering 2025-11-19 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: F573 for Injection for the Treatment of Liver Injury/Failure [Phase 2]